Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial

Saved in:

Bibliographic Details
Published in:	Frontiers in Endocrinology Vol. 14
Main Authors:	Sukanya Siriyotha, Thitiya Lukkunaprasit, Teeranan Angkananard, Panu Looareesuwan, Gareth McKay, John Attia, Ammarin Thakkinstian
Format:	Journal Article
Language:	Japanese
Published:	Frontiers Media SA 30.01.2023
Subjects:	Adverse effect antihyperglycemic drugs Cardiovascular Diseases Cardiovascular Diseases/epidemiology cardiovascular events Continuous Glucose Monitoring diabetes Diabetes mellitus Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 2/complications Dipeptidyl peptidase-4 Dipeptidyl-Peptidase IV Inhibitors Dipeptidyl-Peptidase IV Inhibitors/therapeutic use Diseases of the endocrine glands. Clinical endocrinology dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being Endocrinology Endocrinology, Diabetes and Metabolism FOS: Mathematics Health Sciences Humans Hypoglycemic Agents Hypoglycemic Agents/therapeutic use Insulin Insulin Therapy Internal medicine Linagliptin Management of Diabetes Mellitus and Cardiovascular Risk Management of Diabetes Mellitus and Hypoglycemia Mathematics Medicine Metformin Metformin/therapeutic use Pharmacology Physical Sciences RC648-665 Retrospective cohort study Retrospective Studies SDG 3 - Good Health and Well-being second-line Statistical Methods in Clinical Trials and Drug Development Statistics and Probability Sulfonylurea Compounds Sulfonylurea Compounds/therapeutic use Thiazolidinediones Thiazolidinediones/therapeutic use Treatment Outcome Type 2 diabetes Type 2 Diabetes Mellitus Type 2/complications
ISSN:	1664-2392
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!